TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Fujirebio Diagnostics AB
Closing information (x1000 SEK)
| Closing information | 2025/03 (consolidated) | 2024/03 (consolidated) | 2023/03 (consolidated) |
| Turnover |
313,224
|
321,181
|
310,881 |
| Financial expenses |
15,229
|
4,335
|
84 |
| Earnings before taxes |
138,031
|
167,766
|
177,420 |
| EBITDA |
159,153
|
173,284
|
183,880 |
| Total assets |
721,805
|
774,677
|
644,594 |
| Current assets |
430,526
|
476,219
|
335,504 |
| Current liabilities |
108,772
|
121,458
|
49,799 |
| Equity capital |
604,288
|
645,010
|
587,142 |
| - share capital |
641
|
641
|
641 |
| Employees (average) |
93
|
89
|
86 |
Financial ratios
| Fiscal year | 2025/03 (consolidated) | 2024/03 (consolidated) | 2023/03 (consolidated) |
| Solvency |
83.7%
|
83.3%
|
91.1% |
| Turnover per employee |
3,368
|
3,609
|
3,615 |
| Profit as a percentage of turnover |
44.1%
|
52.2%
|
57.1% |
| Return on assets (ROA) |
21.2%
|
22.2%
|
27.5% |
| Current ratio |
395.8%
|
392.1%
|
673.7% |
| Return on equity (ROE) |
22.8%
|
26.0%
|
30.2% |
| Change turnover |
-7,957
|
10,300
|
45,749 |
| Change turnover % |
-2%
|
3%
|
17% |
| Chg. No. of employees |
4
|
3
|
11 |
| Chg. No. of employees % |
4%
|
3%
|
15% |
Total value of public sale
| Fiscal year | 2025/03 (consolidated) | 2024/03 (consolidated) | 2023/03 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.